Pancreatic Cancer Research

ResearcherUniversity of MichiganNo recent work listed

Ivy Chung

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2840-8123; OpenAlex author ID A5069686944. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper

Papers 3

  1. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cel… First author DOI 10.1016/j.bbagen.2016.10.006↗
  2. Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramming and ROS detoxification. Last author DOI 10.18632/oncotarget.9165↗
  3. Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance. Co-author DOI 10.1158/0008-5472.can-13-1558-t↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuan Seng Wu · 2 shared papers, 2016–2017 · strength 0.16
  2. Chung Yeng Looi · 2 shared papers, 2016–2017 · strength 0.16
  3. Atsushi Masamune · 2 shared papers, 2016–2017 · strength 0.16
  4. Yaqing Zhang · 1 shared paper, 2013 · strength 0.03
  5. Marina Pasca di Magliano · 1 shared paper, 2013 · strength 0.03
  6. Ben Z. Stanger · 1 shared paper, 2013 · strength 0.03
  7. Andrew D. Rhim · 1 shared paper, 2013 · strength 0.03
  8. Meredith A. Collins · 1 shared paper, 2013 · strength 0.03
  9. Filip Bednar · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.